Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1986;6:196-202

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Annamalai, A. E.
Right arrow Articles by Colman, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annamalai, A. E.
Right arrow Articles by Colman, R. W.

Arteriosclerosis, Vol 6, 196-202, Copyright © 1986 by American Heart Association

ARTICLES

Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury

AE Annamalai, GJ Stewart, B Hansel, M Memoli, HC Chiu, DW Manuel, K Doshi and RW Colman

Since human endothelial cells synthesize Factor V but do not secrete it into the medium, we studied the effects of cell injury on the availability of Factor V at the surface of these cells. Human umbilical vein endothelial cells (HUVEC), grown to confluency and incubated with human 125I Factor Va, specifically bound 5000 to 7000 molecules per cell. In the absence of added Va, no antigen was detected on adherent HUVEC with either labeled anti-V(Va) monoclonal or polyclonal IgG. However, exogenous Va, not V, prebound to these cells allows binding of labeled 125I anti-V(Va). Immunodectectibility of bovine Factor V contributed by fetal calf serum in the concentration used in cultures is less than 0.1% of that detected in human plasma. HUVEC, suspended by scraping from dishes, specifically bound 4000 molecules/cell of 125/I monoclonal IgG against V(Va). Although undisturbed cells excluded trypan blue, dye uptake by many of the suspended HUVEC indicated cell injury. Quantitation of injury by 51Cr release after scraping followed by multiple passages through an 18 g needle showed that 51Cr release increased with number of manipulations up to 60% and was observed almost immediately after manipulation. We suggest that little Factor V(Va) is present on the surface of intact adherent HUVEC. However, mechanical injury to HUVEC released or exposed endogenous Factor V(Va), resulting in expression of V that might mediate Factor Xa binding as well as activation of protein C by thrombin. Thus, injured, but not intact, HUVEC could participate in both promoting and limiting blood coagulation.


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Moser and C. Patterson
Thrombin and Vascular Development: A Sticky Subject
Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 922 - 930.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. C. Nicholson, R. L. Nachman, D. C. Altieri, B. D. Summers, W. Ruf, T. S. Edgington, and D. P. Hajjar
Effector Cell Protease Receptor-1 Is a Vascular Receptor for Coagulation Factor Xa
J. Biol. Chem., November 8, 1996; 271(45): 28407 - 28413.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Ambrosini and D. C. Altieri
Molecular Dissection of Effector Cell Protease Receptor-1 Recognition of Factor Xa
J. Biol. Chem., January 12, 1996; 271(2): 1243 - 1248.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.